GlaxoSmithKline: The protection rate of Shingrix vaccine against herpes zoster still reaches 82% after 11 years of injection
王俊杰2017
发表于 2024-4-18 11:05:24
201
0
0
GlaxoSmithKline recently released long-term protection data for the herpes zoster vaccine. Research has shown that for people over 50 years old, the cumulative protection rate from the 6th to 11th year after receiving the Shingrix vaccine is as high as 79.7%, and the protection rate in the 11th year is still as high as 82%. For the population aged 70 and above, the cumulative protection rate from 6 to 11 years is as high as 73.1%. In 2023, the sales of GlaxoSmithKline Shingrix herpes zoster vaccine reached £ 3.446 billion (approximately RMB 31.422 billion), a year-on-year increase of 17%, making it the highest selling heavyweight product of GSK. (21st Century Business Herald)
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Why is it difficult for GlaxoSmithKline's 10 billion dollar single product to sell in the shingles vaccine market in China?
- MSD World's Second Largest Animal Vaccine Research and Development Center Completed in Ningbo
- Pfizer China Dismiss Star Pneumonia Vaccine Product Team and Change to Shanghai Pharmaceutical Agency for Promotion and Sales
- Behind the layoffs of Pfizer's vaccine team: The issuance of 13 batches of Star Vaccine Pei'er has plummeted sharply, and it has also been surrounded by domestic production
- Top 20 US Stock Deals: Pfizer Encounters Double Killing Lawsuit between Diet Drugs and COVID-19 Vaccine
- Merck's Q4 performance exceeded expectations! Strong sales of heavyweight anti-cancer drugs and HPV vaccines
- Li Zhengqing, Senior Vice President Global and President of Research and Development in China at Merck: Nine valent HPV vaccine adds a second dose vaccination program for women aged 9-14, and Merck "increases efforts" to eliminate cervical cancer
- Merck's imported hepatitis A vaccine has been in widespread shortage in China for more than half a year and has not been approved for issuance
- Merck's response to shortage of hepatitis A vaccines: new batches have entered circulation and supply this month
-
每经AI快讯,据亿航智能官微消息,公司EH216-S无人驾驶电动垂直起降航空器(eVTOL)获得巴西国家民航局颁发的试验飞行许可证书,并计划在巴西进行测试和试飞。关于EH216-S无人驾驶eVTOL在巴西的认证,中国民航局 ...
- 潇湘才子
- 昨天 08:41
- 支持
- 反对
- 回复
- 收藏
-
今年7月,美国三大海外“债主”所持美国国债齐刷刷缩水,其中日本美债持仓已降至去年10月以来最低。 根据美国财政部当地时间9月18日公布的国际资本流动报告(TIC),2024年7月,美国前三大海外“债主”日本 ...
- 520hacker
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
上证报中国证券网讯(记者俞立严)9月19日,蔚来全新品牌乐道的首款车型——乐道L60正式上市。新车定位家庭智能电动SUV,在采用BaaS电池租用服务后,L60的售价可低至14.99万元,电池租用月费最低为599元。乐道L6 ...
- anhao007
- 前天 11:03
- 支持
- 反对
- 回复
- 收藏
-
每经记者袁园 日前,国务院印发的《关于加强监管防范风险推动保险业高质量发展的若干意见》提出,以新能源汽车商业保险为重点,深化车险综合改革。 “车险综改”从2015年就已经开始逐步推进了,经过 ...
- moshulong
- 前天 21:50
- 支持
- 反对
- 回复
- 收藏